<?xml version="1.0" encoding="UTF-8"?>
<!--
  Copyright SemanticBits, Northwestern University and Akaza Research
  
  Distributed under the OSI-approved BSD 3-Clause License.
  See http://ncip.github.com/caaers/LICENSE.txt for details.
-->
<p:studies xmlns:p="http://schema.integration.caaers.cabig.nci.nih.gov/study">
    <p:study>
        <shortTitle>Study PCS</shortTitle>
        <longTitle>Pancreatic Cancer Study ph 5</longTitle>
        <precis>Precis</precis>
        <description>Test Study</description>
        <phaseCode>Phase I Trial</phaseCode>
        <status>Active - Trial is open to accrual</status>
        <multiInstitutionIndicator>true</multiInstitutionIndicator>
        <adeersReporting>true</adeersReporting>
        <p:aeTerminology>
            <p:ctcVersion>
                <name>3</name>
            </p:ctcVersion>
        </p:aeTerminology>
        <p:diseaseTerminology>
            <diseaseCodeTerm>MEDDRA</diseaseCodeTerm>
        </p:diseaseTerminology>
        <design>OPEN_UNBLIND</design>
        <drugAdministrationTherapyType>true</drugAdministrationTherapyType>
        <deviceTherapyType>true</deviceTherapyType>
        <radiationTherapyType>true</radiationTherapyType>
        <surgeryTherapyType>true</surgeryTherapyType>
        <behavioralTherapyType>true</behavioralTherapyType>
        <fundingSponsor>
            <organizationAssignedIdentifier>
                <value>CTEP001</value>
            </organizationAssignedIdentifier>
            <p:studyFundingSponsor>
                <p:organization>
                    <name>Cancer Therapy Evaluation Program</name>
                    <nciInstituteCode>CTEP</nciInstituteCode>
                </p:organization>
            </p:studyFundingSponsor>
        </fundingSponsor>
        <coordinatingCenter>
            <organizationAssignedIdentifier>
                <value>WFCCC001</value>
            </organizationAssignedIdentifier>
            <p:studyCoordinatingCenter>
                <p:organization>
                    <name>Cancer and Leukemia Group B</name>
                    <nciInstituteCode>CALGB</nciInstituteCode>
                </p:organization>
            </p:studyCoordinatingCenter>
        </coordinatingCenter>
        <studyOrganizations>
            <p:studySite>
                <p:organization>
                    <name>Cancer Therapy Evaluation Program</name>
                    <nciInstituteCode>CTEP</nciInstituteCode>
                </p:organization>
                <studyInvestigators>
                    <p:studyInvestigator>
                        <roleCode>SPI</roleCode>
                        <statusCode>Active</statusCode>
                        <p:siteInvestigator>
                            <p:investigator>
                                <firstName>Gerry</firstName>
                                <lastName>Elbridge</lastName>
                                <nciIdentifier>Gerry</nciIdentifier>
                            </p:investigator>
                        </p:siteInvestigator>
                    </p:studyInvestigator>
                    <p:studyInvestigator>
                        <roleCode>SI</roleCode>
                        <statusCode>Active</statusCode>
                        <p:siteInvestigator>
                            <p:investigator>
                                <firstName>George</firstName>
                                <lastName>Clinton</lastName>
                                <nciIdentifier>George</nciIdentifier>
                            </p:investigator>
                        </p:siteInvestigator>
                    </p:studyInvestigator>
                </studyInvestigators>
                <studyPersonnels>
                    <p:studyPersonnel>
                        <roleCode>ae_reporter</roleCode>
                        <statusCode>Active</statusCode>
                        <p:researchStaff>
                            <firstName>Mike</firstName>
                            <lastName>Conway</lastName>
                            <nciIdentifier>Mike</nciIdentifier>
                        </p:researchStaff>
                    </p:studyPersonnel>
                </studyPersonnels>
            </p:studySite>
            <p:studySite>
                <p:organization>
                    <name>Johns Hopkins University</name>
                    <nciInstituteCode>MD017</nciInstituteCode>
                </p:organization>
                <studyPersonnels>
                    <p:studyPersonnel>
                        <roleCode>ae_reporter</roleCode>
                        <statusCode>Active</statusCode>
                        <p:researchStaff>
                            <firstName>Allan</firstName>
                            <lastName>Border</lastName>
                            <nciIdentifier>Allan</nciIdentifier>
                        </p:researchStaff>
                    </p:studyPersonnel>
                </studyPersonnels>
            </p:studySite>
        </studyOrganizations>

        <identifiers>
        </identifiers>

        <treatmentAssignments>
            <p:treatmentAssignment>
                <code>theCode1</code>
                <doseLevelOrder>1</doseLevelOrder>
                <description>description1</description>
                <comments>Comments1</comments>
            </p:treatmentAssignment>
            <p:treatmentAssignment>
                <code>theCode3</code>
                <doseLevelOrder>2</doseLevelOrder>
                <description>description3</description>
                <comments>Comments3</comments>
            </p:treatmentAssignment>
        </treatmentAssignments>
        <studyAgents>
            <p:studyAgent>
                <p:agent>
                    <name>1-Aminocyclopentane</name>
                </p:agent>
                <indType>OTHER</indType>
                <partOfLeadIND>false</partOfLeadIND>
                <studyAgentINDAssociations>
                    <p:studyAgentINDAssociation>
                        <p:investigationalNewDrug>
                            <indNumber>222</indNumber>
                            <holderName>Company</holderName>
                        </p:investigationalNewDrug>
                    </p:studyAgentINDAssociation>
                </studyAgentINDAssociations>
            </p:studyAgent>
        </studyAgents>

        <meddraStudyDiseases>
            <p:meddraStudyDisease>
                <meddraCode>10000002</meddraCode>
            </p:meddraStudyDisease>
            <p:meddraStudyDisease>
                <meddraCode>10000003</meddraCode>
            </p:meddraStudyDisease>
        </meddraStudyDiseases>

    </p:study>
</p:studies>
